Device for insertion of a cannula of an infusion device and method

Information

  • Patent Grant
  • 8795309
  • Patent Number
    8,795,309
  • Date Filed
    Tuesday, July 27, 2010
    14 years ago
  • Date Issued
    Tuesday, August 5, 2014
    10 years ago
Abstract
A device for inserting a needle used to introduce a cannula can include a housing including a closed end, an open end, and an arm including a tab extending from the open end, and a sleeve configured to be placed against the patient's skin, the sleeve defining a slot extending along a length of the sleeve, and a barb positioned adjacent to an end of the slot. The slot is sized to receive at least a portion of the arm and the tab of the housing so that the arm and the tab of the housing slides within the slot as the housing is moved relative to the sleeve, and the barb is positioned to engage the tab of the housing to limit movement of the housing relative to the sleeve. The device can also include a threaded portion of the housing extending towards the closed end of the housing.
Description
BACKGROUND

Infusion devices are used to deliver substances such as medications into the subcutaneous layer of skin of a patient. Devices for assisting in insertion of the cannula of an infusion device into the skin of the patient are known. For example, some devices utilize springs to automatically drive a needle into the skin of a patient to introduce the cannula of the infusion device into the subcutaneous layer.


Because a needle is used to introduce the cannula of the infusion device into the subcutaneous layer of skin, there is a risk associated with inadvertent exposure to the needle. Further, patients may react adversely to viewing the needle prior to insertion and may, for example, be reluctant to place the needle into the skin. Prior devices may not adequately shroud this needle prior to and/or after introduction of the infusion device.


Other issues of concern in the design and use of insertion devices include ease of use by the patient and sterilization. For example, some patients may have difficulty loading the infusion device into the insertion device.


SUMMARY

In one aspect, a device for inserting a needle used to introduce a cannula of a subcutaneous infusion device into a subcutaneous layer of skin of a patient includes: a housing including a closed end, an open end, and an arm including a tab extending from the open end; and a sleeve configured to be placed against the patient's skin to introduce the cannula into the patient's skin, the sleeve defining a slot extending along a length of the sleeve, and a barb positioned adjacent to an end of the slot; wherein the slot is sized to receive at least a portion of the arm and the tab of the housing so that the arm and the tab of the housing slides within the slot as the housing is moved relative to the sleeve; and wherein the barb is positioned to engage the tab of the housing to limit movement of the housing relative to the sleeve.


In another aspect, a device for inserting a needle used to introduce a cannula of a subcutaneous infusion device into a subcutaneous layer of skin of a patient includes: a housing including a closed end, an open end, and defining an internal cavity, the housing including a threaded portion positioned adjacent to the open end, the threaded portion extending towards the closed end of the housing; the needle positioned within the internal cavity of the housing and coupled to the cannula of the subcutaneous infusion device; a cap including a cap closed end and a cap open end, the cap including a cap threaded portion positioned adjacent to the open end; wherein the cap threaded portion is coupled to the threaded portion of the housing with the device in a ship state.


In another aspect, a method for inserting a needle used to introduce a cannula of a subcutaneous infusion device into a subcutaneous layer of skin of a patient includes: positioning a tab of a housing in a slot formed by a sleeve of a device; positioning the sleeve against the patient's skin; moving the housing relative to the sleeve to introduce the cannula into the patient's skin; and allowing the tab to slide within the slot as the housing is moved relative to the sleeve.





DESCRIPTION OF THE FIGURES


FIG. 1 is a perspective view of an example embodiment of a device used to introduce a cannula of an infusion device into a patient.



FIG. 2 is a side view of the device of FIG. 1.



FIG. 3 is a cross-sectional view taken along line A-A of the device of FIG. 2.



FIG. 4 is a perspective view of the device of FIG. 1 with a cap removed.



FIG. 5 is a side view of the device of FIG. 4.



FIG. 6 is a cross-sectional view taken along line B-B of the device of FIG. 5.



FIG. 7 is a perspective view of the device of FIG. 3 in a trigger state.



FIG. 8 is a side view of the device of FIG. 7.



FIG. 9 is a cross-sectional view taken along line C-C of the device of FIG. 8.



FIG. 10 is an exploded view of the device of FIG. 1.



FIG. 11 is a perspective view of an example housing of the device of FIG. 1.



FIG. 12 is another perspective view of the housing of FIG. 11.



FIG. 13 is a side view of the housing of FIG. 11.



FIG. 14 is a perspective view of an example sleeve of the device of FIG. 1.



FIG. 15 is another perspective view of the sleeve of FIG. 14.



FIG. 16 is a side view of the sleeve of FIG. 14.



FIG. 17 is an end view of the sleeve of FIG. 14.



FIG. 18 is a perspective view of another example embodiment of a device used to introduce a cannula of an infusion device into a patient.



FIG. 19 is a side view of the device of FIG. 18.



FIG. 20 is a cross-sectional view taken along line D-D of the device of FIG. 19.



FIG. 21 is a perspective view of the device of FIG. 18 with a cap removed.





DETAILED DESCRIPTION

A first embodiment of a device 100 is shown in FIGS. 1-17. As shown in FIG. 10, the device 100 includes a housing 10, a needle hub 1, a cylinder hub 2, a spring 3, a sleeve 15, a site 6 including a septum 5, a holder 4, and an adhesive layer 7, and a removable cap 20.


Generally, the device 100 is used to introduce a cannula 50 associated with the site 6 into the skin of a patient. The site 6 is then disconnected from the device 100, and the site 6 remains on the skin to deliver substances to the patient.


The housing 10 is preferably cylindrical in shape and includes a closed upper end and an open lower end. The housing 10 further preferably includes a knurled exterior surface to enhance a patient's grip on the housing 10, as well as a threaded portion 11 positioned to engage the cap 20, as described further below. The housing 10 includes an internal cavity sized to receive at least a portion of the needle hub 1 and the cylinder hub 2.


The needle hub 1 includes a main body 201 and a needle 202 (hollow or solid) coupled to the main body 201. The needle hub 1 is positioned in the interior passage of the cylinder hub 2 in a fixed position relative to the cylinder hub 2 and the housing 10. See, for example, FIGS. 3, 6, 9.


The cylinder hub 2 is coupled to the upper end of the housing 10. The cylinder hub 2 includes the interior passage into which the needle hub 1 is positioned. As described further below, the needle hub 1 moves longitudinally within the passage formed by the cylinder hub 2.


The spring 3 surrounds a portion of the cylinder hub 2. One end of the spring 3 is seated on the sleeve 15, and the other end of the spring 3 engages the needle hub 1. The spring 3 is in a compressed state as shown in FIGS. 3 and 6 and therefore applies force against the needle hub 1, biasing the needle hub 1 in an upward direction towards the closed end of the housing 10. Likewise, the spring 3 forces the housing 10 and the sleeve 15 apart. Further, as the housing 10 and associated needle hub 1 are moved relative to the sleeve 15, the spring 3 is further compressed until the needle hub 1 is released from the cylinder hub 2, as described below. At that point, the spring 3 forces the needle hub 1 back upward into the housing 10.


The sleeve 15 is preferably cylindrical in shape. The sleeve 15 is coupled to the housing 10 such that the housing 10 can be moved longitudinally with respect to the sleeve 15, as described herein.


The site 6 is loaded into the device 100 prior to application of the adhesive layer 7 onto the device 100. The adhesive layer 7 is pierced by the needle 202 as the needle 202 is advanced towards the skin, as described further below. The adhesive layer 7 maintains the site 6 on the skin of the patient. The site 6 includes the septum 5 that is piercable by a needle of a set configured to deliver medication into the septum 5, through the cannula 50, and into the patient. The holder 4 maintains the septum 5 in position within the site 6.


The cap 20 includes a closed end and an open end. The cap 20 preferably includes an exterior with a knurled surface to enhance the patient's grip on the cap 20. In addition, the interior of the cap 20 includes a threaded portion 21 positioned adjacent the open end so that the threaded portion 21 can be threaded onto the threaded portion 11 of the housing 10 to seal the device 100. See FIGS. 1-3.


As shown in FIGS. 1-9, the device 100 includes a ship state (FIGS. 1-3), a delivery state (FIGS. 4-6), and a trigger state (FIGS. 7-9).


In the ship state shown in FIG. 1-3, the device 100 includes the site 6 in a state such that the site 6 is ready for deployment by the patient after the cap 20 is removed.


In the delivery state shown in FIG. 4-6, the cap 20 has been unscrewed to remove the cap 20 from the device 100. The patient then places an end 23 of the sleeve 15 against the patient's skin at the desired location. In this state, the patient can insert the cannula 50 of the site 6 into the patient's skin. To accomplish this, the needle hub 1 includes the needle 202 that extends through the cannula 50 of the site 6 by depressing the housing 10 to move the needle hub 1 that is coupled thereto so that the needle 202 and associated cannula 50 of the site 6 are introduced into the skin.


In the trigger state shown in FIG. 7-9, the housing 10 has been moved towards the skin until the cannula 50 is fully inserted and the housing 10 has moved adjacent to the sleeve 15. At this state, the spring 3 of the device 100 moves the needle hub up into the housing 10, so that the needle is removed from the skin while leaving the cannula 50 of the site 6 in the skin.


The device 100 can then be removed from the skin and discarded.


As shown in FIGS. 11-13, the housing 10 has three tabs 200 that extend from arms 206 of the housing 10 that engage complementary slots 210 formed along lengths of the sleeve 15 (see FIGS. 14-17) to couple the housing 10 to the sleeve 15. The tabs 200 maintain the connection between the housing 10 and the sleeve 15 while allowing the housing 10 to slide relative to the sleeve 15 in the slots 210 during insertion of the needle and cannula 50 of the site 6 into the skin. At the upper end of each of the slots 210, a barb 212 is formed so that each respective tab 200 engages the barb 212 as the tab 200 slides within the slot 210 to maintain the tab 200 within the slot. See FIGS. 3 and 6.


In addition, in some embodiments, the sleeve 15 includes one or more rails 234 (see FIGS. 14 and 17) that run parallel to the centerline of the sleeve 15 and are positioned adjacent to the slots 210. The rails 234 align with corresponding grooves 232 in the housing 10 (see FIGS. 11-13), so that the rails 234 slide within the grooves 232 during insertion of the needle and cannula 50 of the site 6 into the skin. The engagement of the rails 234 with the grooves 232 maintains the orientation of the housing 10 relative to the sleeve 15 as the housing 10 is slid relative to the sleeve 15 during insertion of the cannula 50. In the example shown, the rails 234 are provided in pairs adjacent to the edges of the slots 210. Other configurations are possible.


Referring now to FIGS. 18-21, another device 300 is shown. The device 300 is similar to the device 100 described above. However, the device 300 includes a housing 302 with a threaded portion 310 that is positioned external from the housing 302 and extends towards a closed end 322 of the housing and away from the sleeve 306, rather than towards the sleeve 306 as shown in the previous embodiment. See FIGS. 20 and 21. In addition, a cap 304 includes an extended portion 320 positioned to be screwed onto the threaded portion 310 of the housing 302.


Additional details regarding some of the components of the devices described herein can be found in U.S. patent application Ser. No. 10/705,719 filed Nov. 10, 2003 and granted as U.S. Pat. No. 7,731,691 on Jun. 8, 2010, the entirety of which is hereby incorporated by reference.


Modifications, permutations, or subsets can be made to the examples described herein without departing from the scope and spirit of the designs.

Claims
  • 1. A device for inserting a needle used to introduce a cannula of a subcutaneous infusion device into a subcutaneous layer of skin of a patient, the device comprising: a housing including a closed end, an open end, and defining an internal cavity, the housing including a threaded portion positioned adjacent to the open end, the threaded portion extending towards the closed end of the housing;a sleeve configured to be placed against the patient's skin to introduce the cannula into the patient's skin, the sleeve defining a slot extending along a length of the sleeve, at least one rail extending parallel to a centerline of the sleeve on the same surface as the slot, and a barb positioned adjacent to an end of the slot;the needle positioned within the internal cavity of the housing and coupled to the cannula of the subcutaneous infusion device; anda cap including a cap closed end and a cap open end, the cap including a cap threaded portion positioned adjacent to the cap open end;wherein the cap threaded portion is coupled to the threaded portion of the housing with the device in a ship state, wherein the rail and the slot are immediately adjacent one another on the same surface.
  • 2. The device of claim 1, wherein the threaded portion of the housing is positioned externally.
  • 3. The device of claim 1, wherein the housing further includes an arm including a tab extending from the open end, wherein the slot is sized to receive at least a portion of the arm and the tab of the housing so that the arm and the tab of the housing slides within the slot as the housing is moved relative to the sleeve,wherein the barb is positioned to engage the tab of the housing to limit movement of the housing relative to the sleeve.
  • 4. The device of claim 3, further comprising a spring configured to move the needle into a retracted state, wherein, upon full introduction of the needle and associated cannula of the subcutaneous infusion device into the subcutaneous layer of skin of the patient, the spring automatically moves the needle into the internal cavity of the housing into the retracted state while leaving the cannula of the subcutaneous infusion device in the subcutaneous layer of skin of the patient.
  • 5. The device of claim 1, further comprising a spring configured to move the needle into a retracted state, wherein, upon full introduction of the needle and associated cannula of the subcutaneous infusion device into the subcutaneous layer of skin of the patient, the spring automatically moves the needle into the internal cavity of the housing into the retracted state while leaving the cannula of the subcutaneous infusion device in the subcutaneous layer of skin of the patient.
  • 6. The device of claim 1, further comprising: a needle hub disposed in the housing to support the needle; anda retracting member surrounding at least a portion of the needle hub and configured to retract the needle hub into the housing.
  • 7. The device of claim 6, wherein the retracting member retracts the needle hub into the housing by torsion from extension of the retracting member.
  • 8. The device of claim 1, wherein the sleeve comprises a continuous surface, and wherein the rail and the slot are immediately adjacent one another on the same continuous surface.
  • 9. The device of claim 1, wherein the housing further comprises an arm including a tab extending from the open end.
  • 10. The device of claim 1, wherein the sleeve includes a circumferential inner surface, and wherein the rail and the slot are immediately adjacent one another on the same circumferential inner surface.
  • 11. The device of claim 1, wherein the rail protrudes from the surface.
  • 12. A device for inserting a needle used to introduce a cannula of a subcutaneous infusion device into a subcutaneous layer of skin of a patient, the device comprising: a housing including a closed end, an open end, and defining an internal cavity, the housing including a threaded portion positioned adjacent to the open end, the threaded portion extending towards the closed end of the housing;a sleeve configured to be placed against the patient's skin to introduce the cannula into the patient's skin, the sleeve defining a slot extending along a length of the sleeve, at least one rail extending parallel to a centerline of the sleeve on the same surface as the slot, and a barb positioned adjacent to an end of the slot;the needle positioned within the internal cavity of the housing and coupled to the cannula of the subcutaneous infusion device; anda cap including a cap closed end and a cap open end, the cap including a cap threaded portion positioned adjacent to the cap open end;wherein the cap threaded portion is coupled to the threaded portion of the housing with the device in a ship state,wherein the slot extends along an entire axial length of the sleeve.
  • 13. The device of claim 12, wherein the rail protrudes from the surface.
  • 14. The device of claim 12, wherein the threaded portion of the housing is positioned externally.
  • 15. The device of claim 12, wherein the housing further includes an arm including a tab extending from the open end, wherein the slot is sized to receive at least a portion of the arm and the tab of the housing so that the arm and the tab of the housing slides within the slot as the housing is moved relative to the sleeve,wherein the barb is positioned to engage the tab of the housing to limit movement of the housing relative to the sleeve.
  • 16. The device of claim 15, further comprising a spring configured to move the needle into a retracted state, wherein, upon full introduction of the needle and associated cannula of the subcutaneous infusion device into the subcutaneous layer of skin of the patient, the spring automatically moves the needle into the internal cavity of the housing into the retracted state while leaving the cannula of the subcutaneous infusion device in the subcutaneous layer of skin of the patient.
  • 17. The device of claim 12, further comprising a spring configured to move the needle into a retracted state, wherein, upon full introduction of the needle and associated cannula of the subcutaneous infusion device into the subcutaneous layer of skin of the patient, the spring automatically moves the needle into the internal cavity of the housing into the retracted state while leaving the cannula of the subcutaneous infusion device in the subcutaneous layer of skin of the patient.
  • 18. The device of claim 12, further comprising: a needle hub disposed in the housing to support the needle; anda retracting member surrounding at least a portion of the needle hub and configured to retract the needle hub into the housing.
  • 19. The device of claim 18, wherein the retracting member retracts the needle hub into the housing by torsion from extension of the retracting member.
  • 20. The device of claim 12, wherein the housing further comprises an arm including a tab extending from the open end.
RELATED APPLICATION

This application claims the benefit of U.S. patent application Ser. No. 61/229,466 filed on Jul. 29, 2009, the entirety of which is hereby incorporated by reference.

US Referenced Citations (99)
Number Name Date Kind
3547119 Hall Dec 1970 A
4531937 Yates Jul 1985 A
4755173 Konopka Jul 1988 A
4805791 Begley Feb 1989 A
4994042 Vadher Feb 1991 A
5092853 Couvertier, II Mar 1992 A
5129884 Dysarz Jul 1992 A
5135496 Vetter Aug 1992 A
5137516 Rand Aug 1992 A
5176650 Haining Jan 1993 A
5176662 Bartholomew Jan 1993 A
5257980 Van Antwerp Nov 1993 A
5451210 Kramer Sep 1995 A
5522803 Teissen-Simony Jun 1996 A
5545143 Fischell Aug 1996 A
5573510 Isaacson Nov 1996 A
5575777 Cover Nov 1996 A
5584813 Livingston Dec 1996 A
5591188 Waisman Jan 1997 A
5676156 Yoon Oct 1997 A
5738641 Watson Apr 1998 A
5817058 Shaw Oct 1998 A
5833666 Davis Nov 1998 A
5848990 Cirelli Dec 1998 A
5851197 Marano Dec 1998 A
5968011 Larsen Oct 1999 A
5980506 Mathiasen Nov 1999 A
6017328 Fischell Jan 2000 A
6056718 Funderburk et al. May 2000 A
6056726 Isaacson May 2000 A
6077244 Botich Jun 2000 A
6086575 Mejslov Jul 2000 A
6093172 Funderburk Jul 2000 A
6123690 Mejslov Sep 2000 A
6159181 Crossman Dec 2000 A
6293925 Safabash Sep 2001 B1
6302866 Marggi Oct 2001 B1
6355021 Nielsen Mar 2002 B1
6450992 Cassidy, Jr. Sep 2002 B1
6520938 Funderburk Feb 2003 B1
6572586 Wojcik Jun 2003 B1
6579267 Lynch Jun 2003 B2
6607509 Bobroff Aug 2003 B2
6620136 Pressly, Sr. Sep 2003 B1
6685674 Douglas Feb 2004 B2
6736797 Larsen May 2004 B1
6830562 Mogensen Dec 2004 B2
6926694 Marano-Ford Aug 2005 B2
7018344 Bressler Mar 2006 B2
7052483 Wojcik May 2006 B2
7056302 Douglas Jun 2006 B2
7303543 Maule et al. Dec 2007 B1
7585287 Bresina et al. Sep 2009 B2
7699807 Faust Apr 2010 B2
7699808 Marrs Apr 2010 B2
7731691 Cote Jun 2010 B2
7850658 Faust Dec 2010 B2
7993306 Marrs et al. Aug 2011 B2
20010053889 Marggi Dec 2001 A1
20020045867 Nielsen Apr 2002 A1
20020077599 Wojcik Jun 2002 A1
20020161332 Ramey Oct 2002 A1
20020173769 Gray Nov 2002 A1
20030014018 Giambattista Jan 2003 A1
20030060781 Mogensen Mar 2003 A1
20030109829 Mogensen Jun 2003 A1
20030125669 Safabash Jul 2003 A1
20030130619 Safabash Jul 2003 A1
20030158520 Safabash Aug 2003 A1
20030199823 Bobroff Oct 2003 A1
20030225373 Bobroff Dec 2003 A1
20030225374 Mathiasen Dec 2003 A1
20040002682 Kovelman Jan 2004 A1
20040143216 Douglas Jul 2004 A1
20040158207 Hunn et al. Aug 2004 A1
20040199123 Nielsen Oct 2004 A1
20040204687 Mogensen Oct 2004 A1
20040215151 Marshall Oct 2004 A1
20040236284 Hoste Nov 2004 A1
20040260250 Harris Dec 2004 A1
20050043687 Mogensen Feb 2005 A1
20050075606 Botich Apr 2005 A1
20050101912 Faust May 2005 A1
20050101932 Cote May 2005 A1
20050101933 Marrs May 2005 A1
20050107743 Fangrow May 2005 A1
20050113761 Faust May 2005 A1
20050131346 Douglas Jun 2005 A1
20050283114 Bresina et al. Dec 2005 A1
20060041224 Jensen Feb 2006 A1
20060129090 Moberg et al. Jun 2006 A1
20060173413 Fan Aug 2006 A1
20080103450 Marrs et al. May 2008 A1
20080243051 DeStefano Oct 2008 A1
20090124979 Raymond et al. May 2009 A1
20090264825 Cote Oct 2009 A1
20090287153 Bresina et al. Nov 2009 A1
20120179106 Cote et al. Jul 2012 A1
20130012881 Lacy Jan 2013 A1
Foreign Referenced Citations (10)
Number Date Country
299 05 072 Sep 1999 DE
202 20 543 Oct 2003 DE
0 290 176 Nov 1988 EP
0 239 244 Sep 1991 EP
0 451 040 Oct 1991 EP
0 615 768 Dec 1999 EP
WO 9632981 Oct 1996 WO
WO 02081012 Oct 2002 WO
WO 02100467 Dec 2002 WO
WO 02102442 Dec 2002 WO
Non-Patent Literature Citations (3)
Entry
International Search Report & Written Opinion submitted in PCT/US2010/043350 on Dec. 3, 2010, 12 pages.
International Search Report and Written Opinion of the International Searching Authority, mailed Dec. 3, 2010, 12 pages.
Application and File History for U.S. Appl. No. 13/619,396 filed Sep. 14, 2012, inventor Lacy.
Related Publications (1)
Number Date Country
20110028982 A1 Feb 2011 US
Provisional Applications (1)
Number Date Country
61229466 Jul 2009 US